Cite
MLA Citation
J Avouac et al.. “SAT0163 Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory rheumatic diseases in daily clinical practice: the experience of cochin hospital, paris, france.” Annals of the rheumatic diseases, vol. 76, n.d., pp. 831–832. http://access.bl.uk/ark:/81055/vdc_100135139165.0x000062